To unravel how neurological diseases progress through the involvement of BAPs and to devise novel therapeutic strategies for managing these conditions, this review explores the clinical significance of amyloid proteins in neurodegenerative diseases, the role of bacterial amyloid proteins, their evolutionary relationships, and potential therapeutic strategies. This evidence concerns the gene GJB2 and nervous system disorder.